Research by Grant Title

Title, Institution[sort] Investigator Award Cycle Award
Ascertainment of environmental tobacco exposure in pregnancy 1999 (Cycle VIII) $2,053,747
Sequoia Foundation Martin Kharrazi Ph.D.
Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth 1998 (Cycle VII) $1,955,276
University of Southern California C. Anderson Johnson Ph.D.
Smoking during pregnancy: chromosome damage in newborns 1999 (Cycle VIII) $1,662,871
Lawrence Livermore National Laboratory James Tucker Ph.D.
Quantitative Genetic Analysis 1998 (Cycle VII) $1,490,600
SRI International Dorit Carmelli Ph.D.
School tobacco program and policy trial 1997 (Cycle VI) $1,162,877
University of Southern California Mary Ann Pentz Ph.D.
Hyperactive nicotine receptors 2000 (Cycle IX) $1,138,225
California Institute of Technology Henry Lester Ph.D.
Reducing Environmental Tobacco Smoke in Latino Children 1997 (Cycle VI) $1,085,128
San Diego State University Research Foundation Terry Conway Ph.D.
Novel DNA vaccines for the treatment of lung cancer 2000 (Cycle IX) $1,063,300
Scripps Research Institute Ralph Reisfeld Ph.D.
Maternal DNA repair of tobacco-induced sperm lesions 1998 (Cycle VII) $1,046,880
Lawrence Livermore National Laboratory Andrew Wyrobek Ph.D.
Effect of tobacco smoke on leucocyte adhesion in vivo 2001 (Cycle X) $1,023,946
La Jolla Institute for Molecular Medicine Pragada Sriramarao Ph.D.
Post-isoprenylation processing steps as anticancer targets 2000 (Cycle IX) $1,017,450
J. David Gladstone Institutes Stephen Young M.D.
Smoking Cessation in Latinos Using Community Health Advisors 1997 (Cycle VI) $992,121
San Diego State University Research Foundation Gregory Talavera M.D., M.P.H.
Mapping of Genetic Loci for Nicotine Dependence 1998 (Cycle VII) $982,095
Ernest Gallo Clinic and Research Center Kirk Wilhelmsen M.D., Ph.D.
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern California Clyde Dent Ph.D.
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern California Rita Leeseman
Mobilized dendritic cells for lung cancer 2000 (Cycle IX) $950,821
Stanford University Edgar Engleman M.D.
Vascular targeting of lung tumors 1999 (Cycle VIII) $899,686
Sidney Kimmel Cancer Center Jan Schnitzer M.D.
Stress and the use of nicotine 2000 (Cycle IX) $897,484
Cedars-Sinai Medical Center Robert Pechnick Ph.D.
Tobacco-related disease in native California twins 1997 (Cycle VI) $889,746
University of Southern California Thomas Mack M.D., M.P.H.
Family factors in smoking acquisition among Latino youth 1998 (Cycle VII) $865,636
San Diego State University Research Foundation Rafael Laniado-Laborin M.D., MPH
Segregation Analysis of Tobacco Use in Families 1998 (Cycle VII) $863,966
SRI International Gary Swan Ph.D.
Suppressor genes of lung cancer 1998 (Cycle VII) $859,254
The Burnham Institute for Medical Research Shi Huang Ph.D.
Tobacco prevention/cessation at continuation schools 2002 (Cycle XI) $848,679
University of Southern California Steve Sussman Ph.D.
Smoking and Risk of Proximal Vs. Distal Gastric Cancer 1994 (Cycle III) $835,887
University of Southern California Anna Wu Ph.D.
Studies of novel antitumor agents for lung carcinoma 2000 (Cycle IX) $833,491
University of California, San Diego Michael Kelner M.D., M.S.
Vascular targeting of lung tumors 2002 (Cycle XI) $830,563
Sidney Kimmel Cancer Center Jan Schnitzer M.D.
Telephone Counseling for Pregnant Smokers 1999 (Cycle VIII) $828,931
University of California, San Diego Shu-Hong Zhu Ph.D.
Culture and Tobacco Among American Indian Adolescents 2006 (Cycle XV) $827,725
University of Southern California Jennifer Unger Ph.D.
Test of an internet virtual world for teen smoking cessation 2002 (Cycle XI) $826,206
San Diego State University Research Foundation Susan Woodruff Ph.D.
Test of an internet virtual world for teen smoking cessation 2002 (Cycle XI) $826,206
San Diego State University Research Foundation James Crittenden
Tobacco use & acculturation: CA residents of Korean descent 2000 (Cycle IX) $825,701
San Diego State University Research Foundation Richard Hofstetter Ph.D.
The effect of tobacco smoke on immune function in twins 1998 (Cycle VII) $822,641
University of Southern California Wendy Cozen D.O., M.P.H.
p53 and p14ARF: Multiple pathways of lung cancer suppression 2002 (Cycle XI) $821,050
Sidney Kimmel Cancer Center Ruth Gjerset Ph.D.
Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle XVI) $818,160
Sidney Kimmel Cancer Center Wanda Reynolds Ph.D.
Smoking, insulin resistance, and endothelial dysfunction 2003 (Cycle XII) $814,989
Stanford University Gerald Reaven M.D.
The role of PARC in pulmonary inflammation 2004 (Cycle XIII) $812,863
La Jolla Institute for Molecular Medicine Ingrid Schraufstatter M.D.
How does cigarette smoke induce cancer? 1997 (Cycle VI) $811,518
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
Novel nicotine cessation therapeutics 2000 (Cycle IX) $802,840
Human BioMolecular Research Institute John Cashman Ph.D.
Social Context of Smoking in Adolescence and Young Adulthood 2007 (Cycle XVI) $802,234
RAND Corporation Joan Tucker Ph.D.
Smoking-induced oxidant stress & platelet integrin alpha.... 2001 (Cycle X) $801,893
The Burnham Institute for Medical Research Jeffrey Smith Ph.D.
Nicotine-dependent recruitment of vascular progenitor cells 2006 (Cycle XV) $799,907
The Burnham Institute for Medical Research William Stallcup Ph.D.
Determining how cholesterol-rich Lp(a) causes heart disease 1998 (Cycle VII) $797,092
J. David Gladstone Institutes Robert Pitas Ph.D.
Por La Vida taking action for tobacco free communities 2000 (Cycle IX) $795,633
University of California, San Diego Ana Navarro Ph.D.
Por La Vida taking action for tobacco free communities 2000 (Cycle IX) $795,633
University of California, San Diego Beatriz Barraza-Roppe B.S.
Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle VIII) $793,474
J. David Gladstone Institutes Yadong Huang M.D., Ph.D.
Does nicotine inhibit anticancer activities of Vitamin A? 1997 (Cycle VI) $788,808
The Burnham Institute for Medical Research Xiao-Kun Zhang Ph.D.
Novel agents for apoptosis of lung cancer 2002 (Cycle XI) $787,977
The Burnham Institute for Medical Research Xiao-Kun Zhang Ph.D.
Tobacco use & policies: San Diego Mexican American residents 2002 (Cycle XI) $786,750
San Diego State University Research Foundation Melbourne Hovell Ph.D., M.P.H.
Novel DNA vaccines for the treatment of lung cancer 2003 (Cycle XII) $783,900
Scripps Research Institute Ralph Reisfeld Ph.D.
Pathophysiology of abnormal remnant metabolism in smokers 2000 (Cycle IX) $783,345
Palo Alto Medical Foundation Research Institute Allen Cooper M.D.
Unraveling lung cancer signaling pathways 2006 (Cycle XV) $780,780
Scripps Research Institute Jiing-Dwan Lee Ph.D.
Integrins and drug resistance in small cell lung cancer 2003 (Cycle XII) $780,144
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Conformationally constrained nicotine vaccines 2005 (Cycle XIV) $778,921
Scripps Research Institute Kim Janda Ph.D.
Telephone counseling for smokers using pharmacotherapy 2000 (Cycle IX) $774,971
University of California, San Diego Shu-Hong Zhu Ph.D.
California AB13 compliance and ethnicity in urban bars 2003 (Cycle XII) $769,266
Pacific Institute for Research and Evaluation Roland Moore BA, MA, Ph.D.
Nicotinic receptors, smoking and Parkinson's Disease 2002 (Cycle XI) $765,971
Stanford University Lorene Nelson Ph.D.
Implementation of tobacco programs in Calif schools 2000 (Cycle IX) $765,192
University of Southern California Louise Rohrbach Ph.D., M.P.H.
Effects of nicotine on fetal hematopoiesis 2007 (Cycle XVI) $764,400
Torrey Pines Institute for Molecular Studies Sophia Khaldoyanidi M.D., Ph.D.
Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle XVI) $762,411
Scripps Research Institute Tsung-Hsien Chuang Ph.D.
Tobacco smoke, inflammation & atherosclerosis 2001 (Cycle X) $754,932
Scripps Research Institute Linda Curtiss Ph.D.
Expos children to secondhand smoke through cntaminated homes 2004 (Cycle XIII) $754,504
San Diego State University Research Foundation Georg Matt Ph.D.
Effect of tobacco smoke on leukocyte adhesion in vivo 1998 (Cycle VII) $754,361
La Jolla Institute for Molecular Medicine Pragada Sriramarao Ph.D.
Weight Gain as a Predictor of Smoking Relapse 1994 (Cycle III) $750,320
SRI International Marcia Ward Ph.D.
Motivation-enhanced teenage tobacco use cessation 1997 (Cycle VI) $750,248
University of Southern California Steve Sussman Ph.D.
Simple exposure indicators for ETS particles 2002 (Cycle XI) $749,647
Lawrence Berkeley National Laboratory Lara Gundel Ph.D.
Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure 1995 (Cycle IV) $746,727
SRI International Keith Webster Ph.D.
Sociocultural Determinants of Menthol Smoking Among Blacks 2006 (Cycle XV) $746,567
Charles R. Drew University of Medicine & Science Bruce Allen DrPH
Developing treatments that lower blood cholesterol levels 1997 (Cycle VI) $746,536
Scripps Research Institute Linda Curtiss Ph.D.
Novel strategy for protecting neurons from injury in stroke 1999 (Cycle VIII) $742,809
Stanford University Robert Sapolsky Ph.D.
Neurobiological substrates of nicotine addiction 1998 (Cycle VII) $742,393
Scripps Research Institute Athina Markou Ph.D.
Women and smoking: from adolescence to young adulthood 2004 (Cycle XIII) $737,742
RAND Corporation Phyllis Ellickson Ph.D.
Antioxidants, cigarette smoking and atherosclerosis 1998 (Cycle VII) $730,640
University of Southern California James Dwyer Ph.D.
Tobacco use and atherosclerosis protection by paraoxonase 2004 (Cycle XIII) $729,234
Scripps Research Institute Linda Curtiss Ph.D.
Smoking, microsatellite instability & gastric cancers 2001 (Cycle X) $729,199
University of Southern California Anna Wu Ph.D.
Environmental contexts of smoking for Southeast Asians 2004 (Cycle XIII) $728,324
Pacific Institute for Research and Evaluation Juliet Lee BA, MA, PhD
IAP Antagonists for lung cancer treatment 2004 (Cycle XIII) $727,658
The Burnham Institute for Medical Research John Reed M.D., Ph.D.
Detection of occult metastases in patients with lung cancer 1999 (Cycle VIII) $723,842
University of Southern California Richard Cote M.D.
Neurobiological substrates of nicotine addiction 2003 (Cycle XII) $723,613
Scripps Research Institute Athina Markou Ph.D.
Vapor-phase organics in ETS: dynamics and exposure 1998 (Cycle VII) $722,775
Lawrence Berkeley National Laboratory Alfred Hodgson B.A.
Role of nicotine in neuro protection 1999 (Cycle VIII) $722,263
The Parkinson's Institute Maryka Quik Ph.D.
Nicotine Self-Administration in an Animal Model 2008 (Cycle XVII) $720,434
Scripps Research Institute George Koob Ph.D.
Mechanism of nicotine action in developing lung 2000 (Cycle IX) $720,281
University of Southern California Carol Wuenschell Ph.D.
Towards gene therapy for tobacco-related vascular disease 1998 (Cycle VII) $719,328
J. David Gladstone Institutes David Dichek M.D.
Dissemination of a smoking cessation program for in patients 1999 (Cycle VIII) $710,621
Stanford University C. Barr Taylor M.D.
Macrophage function in atherosclerosis 2000 (Cycle IX) $709,200
Scripps Research Institute Linda Curtiss Ph.D.
Toxic and irritant pollutants from aged secondhand smoke 2007 (Cycle XVI) $704,901
Lawrence Berkeley National Laboratory Hugo Destaillats Ph.D.
Lipoprotein classes and susceptibility to atherosclerosis 1998 (Cycle VII) $702,940
J. David Gladstone Institutes Stephen Young M.D.
Inflammation, innate immunity, TLRs, and atherosclerosis 2002 (Cycle XI) $697,650
Scripps Research Institute Peter Tobias Ph.D.
Spanish tobacco-related disease self-management: evaluation 1997 (Cycle VI) $693,751
Stanford University Kate Lorig Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans 2007 (Cycle XVI) $693,630
California State University, Long Beach Foundation Robert Friis Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans 2007 (Cycle XVI) $693,630
California State University, Long Beach Foundation Kimthai Kuoch
ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle X) $691,616
J. David Gladstone Institutes Robert Pitas Ph.D.
Quantification of population exposure to secondhand smoke 1997 (Cycle VI) $686,858
Stanford University Paul Switzer Ph.D.
Dysregulation of VSMC signaling induced by nicotine 2001 (Cycle X) $683,510
Stanford University Philip Tsao Ph.D.
Tobacco Alteration of TGF Beta3 Control of Palatogenesis 2002 (Cycle XI) $680,175
University of Southern California Charles Shuler D.M.D, Ph.D.
Smoking prevention for Asian-American college students 2003 (Cycle XII) $679,368
Veterans Medical Research Foundation Mark Myers Ph.D.
Proteins that Remove Atherogeneic Lipoproteins from Blood 1995 (Cycle IV) $678,254
J. David Gladstone Institutes Robert Pitas Ph.D.
Oral clefts, smoking & variation toxin biotransformation 1997 (Cycle VI) $677,128
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Mechanisms by which tobacco accelerates atherosclerosis 1998 (Cycle VII) $675,731
Stanford University John Cooke M.D., Ph.D.
Hyperactive nicotine receptors 2003 (Cycle XII) $675,487
California Institute of Technology Henry Lester Ph.D.
Internet-enhanced proactive telephone counseling 2002 (Cycle XI) $674,731
Veterans Medical Research Foundation Leslie Lenert M.D., M.S.
Gastroschisis: maternal smoking and genetic variation 2007 (Cycle XVI) $673,269
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Exposure to Secondhand Smoke: Effects of Proximity 2007 (Cycle XVI) $672,582
Stanford University Lynn Hildemann Ph.D.
Comprehensive evaluation of the ischemic leg 2000 (Cycle IX) $672,390
Stanford University Dwight Nishimura Ph.D.
Vitamin A derivatives as antagonists of nicotine effects 2004 (Cycle XIII) $670,085
The Burnham Institute for Medical Research Xiao-Kun Zhang Ph.D.
Improved therapy of lung cancer 2000 (Cycle IX) $668,814
California Pacific Medical Center Research Institute Li-Xi Yang M.D., Ph.D.
Improved chemoradiotherapy of lung cancer 2005 (Cycle XIV) $661,920
California Pacific Medical Center Research Institute Li-Xi Yang M.D., Ph.D.
Negative effects of smoke on novel HDL mimetic therapies 2008 (Cycle XVII) $661,125
Lawrence Berkeley National Laboratory John Bielicki Ph.D.
Nicotine self-administration in an animal model 2003 (Cycle XII) $660,156
Scripps Research Institute George Koob Ph.D.
Therapies of muscle dysfunction in obstructive lung disease 1997 (Cycle VI) $659,714
LA Biomedical Research Institute at Harbor-UCLA Medical Center Richard Casaburi M.D., Ph.D.
Smoking induced dopamine release: buproprion effects 2002 (Cycle XI) $659,060
Brentwood Biomedical Research Institute Arthur Brody M.D.
Experimental evaluation of minors' access to tobacco 2000 (Cycle IX) $655,347
San Diego State University Research Foundation Hope Landrine Ph.D.
Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer 2008 (Cycle XVII) $655,000
Beckman Research Institute of the City of Hope Timothy O'Connor Ph.D.
Analysis of the Hippo pathway in lung cancer 2008 (Cycle XVII) $654,999
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
SHS Exacerbates cerebral ischemia: endothelial mechanisms 2005 (Cycle XIV) $654,854
Stanford University John Cooke M.D., Ph.D.
Pharmacogenetics of Smoking Cessation 2006 (Cycle XV) $653,384
Stanford University Greer Murphy M.D., Ph.D.
NRT and paroxetine for smoking cessation 1997 (Cycle VI) $646,916
Stanford University Joel Killen Ph.D.
Role of nicotine/nicotinic receptors in Parkinson's disease 1998 (Cycle VII) $644,770
The Parkinson's Institute Maryka Quik Ph.D.
Molecular Dynamics & Regulation of Apo A-I's Conformation 2007 (Cycle XVI) $644,293
Children's Hospital Oakland Research Institute Michael Oda Ph.D.
Effect of Tobacco on Rat Lung Alveolar Lining Liquid 1995 (Cycle IV) $643,213
Lawrence Berkeley National Laboratory Jacob Bastacky M.D.
Mechanisms underlying diaphragm adaptations in emphysema 1998 (Cycle VII) $642,624
Cedars-Sinai Medical Center Mario Fournier Ph.D.
Nicotine and cardiac vulnerability to fibrillation 2002 (Cycle XI) $641,821
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Transdermal nicotine for smokers with schizophrenia 2001 (Cycle X) $640,429
LA Biomedical Research Institute at Harbor-UCLA Medical Center Michael Smith M.D.
Reducing provision of tobacco to minors from social sources 1998 (Cycle VII) $639,838
Stanford University Stephen Fortmann M.D.
Smoking and variation of cardiovascular disease genes 2002 (Cycle XI) $635,131
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Nicotinic receptors in nicotine addiction 2008 (Cycle XVII) $634,779
California Institute of Technology Henry Lester Ph.D.
Indoor measurements of environmental tobacco smoke 1997 (Cycle VI) $634,217
Lawrence Berkeley National Laboratory Richard Sextro Ph.D.
Anabolic therapies for muscle dysfunction in women with COPD 2001 (Cycle X) $632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center Richard Casaburi M.D., Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure 2001 (Cycle X) $630,710
Scripps Research Institute Cindy Ehlers Ph.D.
ApoE related effect of smoking in cardiovascular disease 2008 (Cycle XVII) $630,561
Children's Hospital Oakland Research Institute Vasanthy Narayanaswami Ph.D.
Understanding Nicotinic Receptor Subtype Specificity 2007 (Cycle XVI) $630,295
California Institute of Technology Dennis Dougherty BS, MS, Ph.D.
Nicotine and congenital heart disease 2008 (Cycle XVII) $629,797
Stanford University Ching-Pin Chang M.D., PH.D
Novel imaging methods for diagnosing tobacco related cancers 1997 (Cycle VI) $629,087
Stanford University Albert Macovski Ph.D.
Role of passive smoke on sperm, ICSI and IVF 1998 (Cycle VII) $628,862
University of California, San Diego Hillary Klonoff-Cohen Ph.D.
Heparan sulfate small molecules for contro tumor cell growth 2005 (Cycle XIV) $626,807
California Institute of Technology Linda Hsieh-Wilson Ph.D.
Behavioral epidemiology of tobacco use among gay men 1998 (Cycle VII) $626,433
University of California, San Francisco Greg Greenwood Ph.D.
Behavioral effects of neonatal nicotine exposure 2000 (Cycle IX) $624,780
San Diego State University Research Foundation Edward Riley Ph.D.
Brain nAChR Occupancy: Effect of Secondhand Smoke 2007 (Cycle XVI) $623,841
Brentwood Biomedical Research Institute Arthur Brody M.D.
Oral clefts, smoking & variation of toxin biotransformation 2004 (Cycle XIII) $623,472
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Geography of underage tobacco retail sales in Los Angeles 2003 (Cycle XII) $622,260
Pacific Institute for Research and Evaluation Robert Lipton BA, MA, MPH, Ph.D.
Smokeless tobacco cessation among lumber mill employees 1997 (Cycle VI) $620,213
University of Southern California Clyde Dent Ph.D.
Novel regulatory mechanisms for lung cancer growth 2001 (Cycle X) $620,032
Veterans Medical Research Foundation Randolph Hastings M.D., Ph.D.
Role of oxidative stress and mitochondria in COPD 2008 (Cycle XVII) $616,380
University of Southern California Enrique Cadenas Ph.D.
Vasoactive Mediators of Fetal Growth Retardation 1995 (Cycle IV) $615,296
Cedars-Sinai Medical Center Lony Castro M.D.
Dissuading at-risk youth from smoking via mass media 2000 (Cycle IX) $610,340
University of California, Irvine Cornelia Pechmann Ph.D.
Smoking Policies and Secondhand Smoke in Rental Cars 2006 (Cycle XV) $609,853
San Diego State University Research Foundation Georg Matt Ph.D.
Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle XIII) $608,740
Lawrence Berkeley National Laboratory Francesco Marchetti Ph.D.
Nicotine-pathological angiogenesis and genetic determinants 2002 (Cycle XI) $608,420
Stanford University John Cooke M.D., Ph.D.
-Heterologous Expression of Brain Nicotinic Acetylcholine Re 1995 (Cycle IV) $598,774
California Institute of Technology Henry Lester Ph.D.
A novel approach to prevent in utero nicotine lung injury 2005 (Cycle XIV) $597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
Human neurophysiology of nicotine analgesia: sex differences 2000 (Cycle IX) $595,994
University of California, San Francisco David Becker Ph.D.
A dynamic model of smoking and healthcare expenditures in CA 2000 (Cycle IX) $595,843
University of California, San Francisco Wendy Max Ph.D.
ETS effects on breathing patterns 2000 (Cycle IX) $590,780
University of California, Davis Jesse Joad M.D.
Cytokine gene-modified dendritic cells for lung cancer 2000 (Cycle IX) $590,523
University of California, Los Angeles Steven Dubinett M.D.
Smoking prevention for Asian-American college students 2001 (Cycle X) $588,595
Veterans Medical Research Foundation Mark Myers Ph.D.
RCT of tobacco dependence treatment benefits in an HMO & PPO 2000 (Cycle IX) $582,472
University of California, Berkeley Helen Halpin Ph.D.
A longitudinal study of smoking transitions in youth 1999 (Cycle VIII) $577,574
University of California, San Diego Elizabeth Gilpin M.S.
Chronic nicotine treatment in primates; role of a6b2 nAChRs 2008 (Cycle XVII) $577,128
The Parkinson's Institute Maryka Quik Ph.D.
Membrane Signaling Pathways of RAS/RAB Proteins 1995 (Cycle IV) $574,559
Scripps Research Institute William Balch Ph.D.
DNA replication, regulation of the cell cycle, and cancer 2000 (Cycle IX) $571,742
California Institute of Technology Judith Campbell Ph.D.
Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle IV) $569,759
Palo Alto Medical Foundation Research Institute Beatriz Levy-Wilson Ph.D.
Patterns of tobacco use from adolescence to young adulthood 1997 (Cycle VI) $565,277
RAND Corporation Phyllis Ellickson Ph.D.
Effects of passive smoking and pregnancy 1999 (Cycle VIII) $565,186
Lawrence Livermore National Laboratory Kenneth Turteltaub Ph.D.
A Novel Approach to Prevent in Utero Nicotine Lung Injury 2008 (Cycle XVII) $564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
Classroom animation tobacco awareness program effectiveness 2004 (Cycle XIII) $558,761
WestEd Barbara Dietsch Ph.D.
Classroom animation tobacco awareness program effectiveness 2004 (Cycle XIII) $558,761
WestEd Diane Schwartz M.A.
The role of multiple genes in susceptibility to smoking 1997 (Cycle VI) $557,829
Beckman Research Institute of the City of Hope David Comings M.D.
Oxidative stress and skeletal muscle dysfunction in COPD 2006 (Cycle XV) $555,000
University of California, San Diego Russell Richardson Ph.D.
A stage-based scheduled smoking intervention for Chinese 2005 (Cycle XIV) $554,500
University of California, San Francisco Janice Tsoh Ph.D.
Smoke-free bars: analysis of the response from Long Beach 1998 (Cycle VII) $552,978
California State University, Long Beach Foundation Robert Friis Ph.D.
Keep me smokefree 1998 (Cycle VII) $550,002
Education Training and Research Associates, Inc. Carol D'Onofrio DrPH
Human tryptase gene expression: role in COPD 2000 (Cycle IX) $545,409
University of California, San Francisco George Caughey M.D.
Hmong smoking prevalence & tobacco uses 2001 (Cycle X) $539,350
California State University, Fresno Foundation Pao Fang
Hmong smoking prevalence & tobacco uses 2001 (Cycle X) $539,350
California State University, Fresno Foundation Vickie Krenz Ph.D., M.S.P.H.
Internet health research center: smoking, Latinos, & the Web 2004 (Cycle XIII) $535,096
University of California, San Francisco Ricardo Munoz Ph.D.
Smoking predictors in Mexican American youth 1997 (Cycle VI) $534,603
University of San Francisco Gerardo Marin Ph.D.
A Smokeless Tobacco Cessation Program: High School Athletes 1995 (Cycle IV) $533,923
University of California, San Francisco Margaret Walsh MS, EdD
Relationship of perceived risks and benefits to teen smoking 2005 (Cycle XIV) $532,037
University of California, San Francisco Bonnie Halpern-Felsher Ph.D.
LDL pathophysiology and lipoprotein structure 2003 (Cycle XII) $527,245
Children's Hospital Oakland Research Institute Robert Ryan Ph.D.
Integrin Cytoplasmic Domains and Ligand Affinity Modulation 1994 (Cycle III) $522,649
Scripps Research Institute Timothy O'Toole Ph.D.
Effect of nicotine on bone marrow cells 2001 (Cycle X) $520,381
La Jolla Institute for Molecular Medicine Sophia Khaldoyanidi M.D., Ph.D.
Spanish/English web site for smoking cessation trials 2001 (Cycle X) $519,674
University of California, San Francisco Ricardo Munoz Ph.D.
Nicotine in the Brain 2000 (Cycle IX) $518,966
University of California, San Diego Darwin Berg Ph.D.
Correlates of cigarette craving in acute nicotine withdrawal 2003 (Cycle XII) $517,818
Brentwood Biomedical Research Institute Richard Olmstead Ph.D.
The role of hCDC4 regulation of cyclin E in lung cancer 2003 (Cycle XII) $517,032
Sidney Kimmel Cancer Center Charles Spruck Ph.D.
Association of Outlet Density with Smoking and Pack Price 2008 (Cycle XVII) $516,285
Stanford University Lisa Henriksen Ph.D.
Nicotine withdrawal, smoking & attention: an fMRI study 2001 (Cycle X) $515,303
University of California, Los Angeles Edythe London Ph.D.
Immunopharmacotherapy as a treatment for nicotine addiction 2002 (Cycle XI) $515,270
Scripps Research Institute Kim Janda Ph.D.
Effects of nicotine withdrawal on aviator performance 2001 (Cycle X) $515,243
Stanford University Jerome Yesavage M.D.
Effect of maternal smoking on human placental development 2000 (Cycle IX) $515,124
University of California, San Francisco Susan Fisher Ph.D.
Tobacco Control Digital Library 1999 (Cycle VIII) $514,796
University of California, San Francisco Karen Butter M.L.
Parkinson's Disease: A Protective Effect of Smoking? 1999 (Cycle VIII) $512,849
Stanford University Lorene Nelson Ph.D.
Role of Pneumocystis in COPD Progression 2005 (Cycle XIV) $512,737
University of Southern California Ahmet Baydur M.D.
Protecting the "hood" against tobacco: cessation project 2003 (Cycle XII) $512,200
University of California, San Francisco Ruth Malone Ph.D., R.N.
Protecting the "hood" against tobacco: cessation project 2003 (Cycle XII) $512,200
University of California, San Francisco Carol McGruder B.A.
Novel Office-Based Device for Imaging Vocal Cord Cancer 2003 (Cycle XII) $510,000
University of California, Irvine Brian Wong M.D., Ph.D.
Tobacco Industry Targeting of Older Persons 2007 (Cycle XVI) $509,993
University of California, San Francisco Ruth Malone Ph.D., R.N.
Determinants of smoking among gay & lesbian youth 2000 (Cycle IX) $509,771
University of California, San Francisco Jay Paul Ph.D.
Targeting Hypoxia-inducible Factor to Treat Lung Cancer 2003 (Cycle XII) $509,490
The Burnham Institute for Medical Research Siva Kolluri Ph.D.
Cotinine Metabolism in Infants and Children 2006 (Cycle XV) $509,473
University of California, San Francisco Neal Benowitz M.D.
Hypnosis for Smoking Relapse Prevention 2007 (Cycle XVI) $509,353
University of California, San Francisco Timothy Carmody Ph.D.
Use of entertainment education on TV to deter youth smoking 2005 (Cycle XIV) $509,320
University of California, Irvine Cornelia Pechmann Ph.D.
Reaching and Treating LGBT Smokers: The Internet and NRT 2006 (Cycle XV) $509,201
University of California, San Francisco Gary Humfleet Ph.D.
Clinical Pharmacology of Tobacco Alkaloids 2006 (Cycle XV) $508,848
University of California, San Francisco Peyton Jacob Ph.D.
Passive smoking, inflammatory markers and childhood asthma 2003 (Cycle XII) $508,299
University of California, San Diego Hillary Klonoff-Cohen Ph.D.
Smoking Policies and Secondhand Smoke in Hotel Rooms 2008 (Cycle XVII) $508,293
San Diego State University Research Foundation Georg Matt Ph.D.
School-based tobacco control programming for deaf/hh youth 2003 (Cycle XII) $506,967
University of California, Los Angeles Barbara Berman Ph.D.
School-based tobacco control programming for deaf/hh youth 2003 (Cycle XII) $506,967
University of California, Los Angeles Debra Sue Guthmann Ed..D.
Measuring prenatal tobacco exposure in newborn blood spots 2008 (Cycle XVII) $506,927
Sequoia Foundation Juan Yang Ph.D.
Effect of maternal smoking on early human development 2003 (Cycle XII) $505,975
University of California, San Francisco Susan Fisher Ph.D.
Therapy for muscle dysfunction in COPD: cellular adaptations 1998 (Cycle VII) $502,904
Cedars-Sinai Medical Center Michael Lewis M.D.
Controlled study of withdrawal symptoms in teen smokers 2003 (Cycle XII) $499,890
Stanford University Joel Killen Ph.D.
Natural history of tobacco addiction in adolescents 1998 (Cycle VII) $499,505
University of California, San Francisco Anna-Barbara Moscicki M.D.
Two approaches to referral for smoking cessation treatment 2001 (Cycle X) $496,836
University of California, Los Angeles Scott Eliot Sherman M.D., M.P.H.
Adolescent susceptibility to tobacco: a panel analysis 2001 (Cycle X) $495,433
University of California, Irvine Larry Jamner Ph.D.
Determinants of Susceptibility to Oxidized Lipoproteins 1995 (Cycle IV) $495,384
University of California, Los Angeles Alan Fogelman M.D.
Nicotine & behavioral regulation in adult ADHD 2005 (Cycle XIV) $495,092
University of California, Irvine Jean-G. Gehricke Ph.D.
The impact of secondhand smoke exposure on COPD outcomes 2008 (Cycle XVII) $492,890
University of California, San Francisco Mark Eisner M.D., M.P.H.
An athletic trainer mediated spit tobacco cessation program 1998 (Cycle VII) $490,546
University of California, San Francisco Margaret Walsh MS, EdD
Effect of Maternal Smoking on Early Human Development 2006 (Cycle XV) $489,025
University of California, San Francisco Susan Fisher Ph.D.
Passive Smoking: Role of Airways Reactivity in Infancy 1995 (Cycle IV) $486,888
University of California, Berkeley Ira Tager M.D., M.P.H.
Hyperactive nicotine receptors 1997 (Cycle VI) $486,158
California Institute of Technology Henry Lester Ph.D.
ETS Effects on airway development in the primate lung 1998 (Cycle VII) $483,652
University of California, Davis Kent Pinkerton Ph.D.
Persistent smoking in bars: an ethnographic analysis 2001 (Cycle X) $482,317
Pacific Institute for Research and Evaluation Roland Moore BA, MA, Ph.D.
High Resolution OCT for Early Airway Cancer Detection 2007 (Cycle XVI) $480,636
University of California, Irvine Matthew Brenner M.D.
Low-Cost Contingency Management for Smoking Cessation 2008 (Cycle XVII) $478,751
University of California, San Francisco Timothy Carmody Ph.D.
Smokefree Homes and Smoking Initiation in a National Sample 2008 (Cycle XVII) $478,281
University of California, San Diego John Pierce Ph.D.
Bupropion for hospital-based smoking cessation 2003 (Cycle XII) $478,065
University of California, San Francisco Joel Simon M.D., M.P.H.
Nonsmokers helping smokers and the role of culture 2004 (Cycle XIII) $476,656
University of California, San Diego Shu-Hong Zhu Ph.D.
Analysis of California adolescent tobacco data 2001 (Cycle X) $475,742
University of California, Los Angeles William McCarthy Ph.D.
Role of Smad protein in growth inhibition of tumor cells 2000 (Cycle IX) $474,492
Lawrence Berkeley National Laboratory Kunxin Luo Ph.D.
Cigarette smoke alters lipoprotein & artery wall interaction 1997 (Cycle VI) $472,876
University of California, Los Angeles Alan Fogelman M.D.
Effects of prenatal nicotine exposure on nicotinic receptors 2000 (Cycle IX) $471,654
University of California, San Francisco Peter Sargent Ph.D.
Bupropion for smoking cessation 1998 (Cycle VII) $471,154
University of California, San Francisco Joel Simon M.D., M.P.H.
Tobacco exposure in pregnant women in minority populations 2004 (Cycle XIII) $469,727
Sequoia Foundation Martin Kharrazi Ph.D.
Diaphragm adaptations following treatment for emphysema 1997 (Cycle VI) $469,400
Cedars-Sinai Medical Center Michael Lewis M.D.
Diabetes & tobacco exposure in So CA American Indians 2005 (Cycle XIV) $468,390
University of California, San Diego Deborah Morton Ph.D.
Birth defects, smoking and host susceptibility 2003 (Cycle XII) $466,200
March of Dimes Birth Defects Foundation Suzan Carmichael Ph.D.
Nicotine Metabolism in Families 1998 (Cycle VII) $465,537
University of California, San Francisco Neal Benowitz M.D.
Carbon monoxide and the brain growth spurt 1998 (Cycle VII) $464,268
University of California, Los Angeles John Edmond Ph.D.
Pager-assisted smoking cessation treatment 2002 (Cycle XI) $463,689
University of California, San Francisco Timothy Carmody Ph.D.
Environmental tobacco smoke exposure & adult asthma 2001 (Cycle X) $460,032
University of California, San Francisco Mark Eisner M.D., M.P.H.
Effects of nicotine on postinfarction cardiac remodeling 1998 (Cycle VII) $459,799
University of California, San Diego Francisco Villarreal M.D., Ph.D.
Lung volume reduction surgery in an animal emphysema model 2000 (Cycle IX) $456,336
University of California, Irvine Matthew Brenner M.D.
Adolescent Susceptibility to Tobacco: A Panel Analysis 1997 (Cycle VI) $456,076
University of California, Irvine Larry Jamner Ph.D.
Predictors of Smoking in African American Adolescents 1997 (Cycle VI) $455,536
University of California, San Francisco Mark Alexander Ph.D.
Fertility, smoking and early mammalian development 2001 (Cycle X) $454,490
University of California, Riverside Prudence Talbot Ph.D.
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke 1995 (Cycle IV) $454,365
Lawrence Berkeley National Laboratory Rolf Mehlhorn Ph.D.
Novel therapy for pancreatic cancer 1997 (Cycle VI) $452,332
University of California, Irvine Hung Fan Ph.D.
Fertility, smoking and early mammalian development 1997 (Cycle VI) $452,243
University of California, Riverside Prudence Talbot Ph.D.
Serum cotinine levels and reproductive outcomes 1997 (Cycle VI) $452,159
Public Health Institute Martin Kharrazi Ph.D.
Transdermal nicotine replacement for hospitalized smokers 1997 (Cycle VI) $451,969
University of California, San Francisco Joel Simon M.D., M.P.H.
Spanish/English web site for smoking cessation trials 1998 (Cycle VII) $450,400
University of California, San Francisco Ricardo Munoz Ph.D.
Effect of maternal smoking on human placental development 1997 (Cycle VI) $450,000
University of California, San Francisco Susan Fisher Ph.D.
Effect of Smoking on Success Rate of In Vitro Fertilization 1995 (Cycle IV) $449,805
University of California, San Diego Hillary Klonoff-Cohen Ph.D.
Smoking initiation among Chinese and Vietnames adolescents 1997 (Cycle VI) $449,734
University of California, San Francisco Celia Kaplan DrPH
ETS exposures in the California Teachers Study cohort 1998 (Cycle VII) $449,677
Public Health Institute Peggy Reynolds Ph.D.
Effects of environmental tobacco smoke on the artery wall 1998 (Cycle VII) $449,673
University of California, Davis John Rutledge M.D.
Cardiovascular responses through spinal nicotinic receptors 2001 (Cycle X) $448,941
University of California, San Diego Palmer Taylor Ph.D.
Reactivity of surface nicotine towards indoor ozone 2003 (Cycle XII) $448,132
Lawrence Berkeley National Laboratory Hugo Destaillats Ph.D.
Does tobacco exposure delay conception? 2003 (Cycle XII) $447,845
Sequoia Foundation Michelle Pearl Ph.D.
Inflammatory compounds:role in tobacco-related lung disease 1998 (Cycle VII) $447,367
University of California, San Diego Timothy Bigby M.D.
ETS effects on pulmonary breathing patterns 1997 (Cycle VI) $446,954
University of California, Davis Jesse Joad M.D.
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing 1997 (Cycle VI) $446,947
University of California, Los Angeles Barbara Berman Ph.D.
Nicotine toxicity acting on cardiac neurons 1997 (Cycle VI) $446,920
University of California, San Diego Darwin Berg Ph.D.
Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle IV) $446,225
Scripps Research Institute Cindy Ehlers Ph.D.
Molecular origins of ApoB atherogenic lipoproteins 2000 (Cycle IX) $445,617
University of California, San Francisco Robert Hamilton Ph.D.
Smoking interventions in diverse LGBT communities 2002 (Cycle XI) $445,068
Progressive Research & Training for Action Brenda Crawford
Gene therapy for emphysema 1997 (Cycle VI) $443,179
University of California, San Francisco Francis Szoka Ph.D.
Analysis of tobacco industry documents on scientific researc 2000 (Cycle IX) $442,646
University of California, San Francisco Lisa Bero Ph.D.
Passive Smoking and Clara Cell Development in the Lungs 1995 (Cycle IV) $442,317
University of California, Davis Kent Pinkerton Ph.D.
Environmental tobacco smoke and newborn lung development 1997 (Cycle VI) $440,500
University of California, Davis Kent Pinkerton Ph.D.
Comprehensive Tobacco Policy Model 1997 (Cycle VI) $439,963
University of California, Irvine Tammy Tengs Sc.D.
Clinical pharmacology of tobacco alkaloids 1998 (Cycle VII) $439,882
University of California, San Francisco Peyton Jacob Ph.D.
Dissemination of the Rx for Change in Psychiatry Curriculum 2008 (Cycle XVII) $439,283
University of California, San Francisco Judith Prochaska Ph.D., M.P.H.
Nicotonic receptors: role in addiction and reproduction 1997 (Cycle VI) $437,480
Salk Institute for Biological Studies Stephen Heinemann Ph.D.
Nicotine May Affect Inflammation 1999 (Cycle VIII) $435,425
University of California, San Francisco Frederick Jia-Pei Miao M.D., Ph.D.
Bispecific molecular therapy of small cell lung cancer 2001 (Cycle X) $434,805
University of California, San Diego Edward Ball M.D.
Developmental Relationship between NK and T-Cell Lineages 1995 (Cycle IV) $434,126
California Institute of Technology Ellen Rothenberg Ph.D.
The role of media in smoking initiation and cessation 1997 (Cycle VI) $433,880
University of California, San Diego David Burns M.D.
Supplement to tobacco disease in twins 1999 (Cycle VIII) $432,989
University of Southern California Thomas Mack M.D., M.P.H.
How does smoke activate mucin transcription in lung cells? 1998 (Cycle VII) $432,415
University of California, San Francisco Carol Basbaum Ph.D.
Smoking treatment for substance abusing adolescents 1998 (Cycle VII) $431,607
University of California, San Diego Mark Myers Ph.D.
Patterns of tobacco use from adolescence to young adulthood 2001 (Cycle X) $431,132
RAND Corporation Phyllis Ellickson Ph.D.
Neurotransmitter systems and tobacco smoking 1999 (Cycle VIII) $430,910
University of California, Los Angeles Richard Olmstead Ph.D.
Cardiovascular responses to nicotine 1997 (Cycle VI) $430,843
University of California, San Diego Palmer Taylor Ph.D.
To identify Egr-1 target genes important in pulmonary diseas 2000 (Cycle IX) $430,539
The Burnham Institute for Medical Research Ian de Belle Ph.D.
Smoking Cessation in Vietnamese: A Controlled Trial 1995 (Cycle IV) $429,006
University of California, San Francisco Steve McPhee M.D.
Interactions of Moesin during platelet activation 1995 (Cycle IV) $428,524
Stanford University Heinz Furthmayr M.D.
Tobacco oxidants and the ceramide path in lung cell death 1999 (Cycle VIII) $427,613
University of California, Davis Tzipora Goldkorn BSc, MSc, Ph.D.
Context & consequenes of smoking in a blue-collar cohort 2005 (Cycle XIV) $426,555
Pacific Institute for Research and Evaluation Carol Cunradi Ph.D., M.P.H.
Quantification of lung doses from inhaled tobacco smoke 1997 (Cycle VI) $425,728
University of California, Irvine Robert Phalen Ph.D.
Role of thioredoxin in ETS-induced pulmonary airway injury 1998 (Cycle VII) $425,665
University of California, Davis Reen Wu Ph.D.
Effectiveness of a large prenatal tobacco reduction program 2004 (Cycle XIII) $425,181
Sequoia Foundation Michelle Pearl Ph.D.
Modeling sleep disturbance during nicotine withdrawal 2002 (Cycle XI) $424,344
SRI International Teresa Steininger Ph.D.
Ethnic and gender variation in nicotine detoxification 2003 (Cycle XII) $424,142
SRI International Huijun Ring Ph.D.
Environmental tobacco smoke effects on lung surfactant 1999 (Cycle VIII) $423,216
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
Ethnicity and school-level effect on CA student tobacco use 2004 (Cycle XIII) $422,120
University of California, Los Angeles William McCarthy Ph.D.
Chemotherapeutic inhibition of polysialic acid biosynthesis 2003 (Cycle XII) $420,781
University of California, Davis Jacquelyn Gervay-Hague Ph.D.
NF-kB mediated inflammation in tobacco-induced lung cancer 2006 (Cycle XV) $420,000
University of California, San Diego Michael Karin Ph.D.
Epigenetic Regulation of Airway MUC gene expression by smoke 2007 (Cycle XVI) $420,000
University of California, Davis Reen Wu Ph.D.
Nicotinic Manipulation of the Hippocampus 2007 (Cycle XVI) $420,000
University of California, San Diego Darwin Berg Ph.D.
Protective function of VEGF on the development of emphysema 2003 (Cycle XII) $420,000
University of California, San Diego Kechun Tang M.D., Ph.D.
Activation and detoxification of lung cancer carcinogens 2006 (Cycle XV) $420,000
University of California, San Diego Robert Tukey Ph.D.
Use of existing data to dvlp new tobacco control strategies 2003 (Cycle XII) $419,888
University of California, San Diego Karen Messer Ph.D.
Brain imaging in nicotine addiction 2002 (Cycle XI) $419,881
University of California, Los Angeles Desmond Smith Ph.D.
Use of Existing Data to Develop Tobacco Control Strategies 2006 (Cycle XV) $419,720
University of California, San Diego Karen Messer Ph.D.
Neurobiological substrates of nicotine addiction 2006 (Cycle XV) $419,503
University of California, San Diego Athina Markou Ph.D.
Regulations of phase II genes by oxidation products 2005 (Cycle XIV) $419,500
University of California, Merced Henry Forman Ph.D.
Immune Targeted Therapy for Lung Cancer 2006 (Cycle XV) $419,500
University of California, Los Angeles Sherven Sharma Ph.D.
Molecular predictors of oral cancer development 2002 (Cycle XI) $419,000
University of California, San Francisco Richard Charles Jordan D.D.S., Ph.D.
ETS Effects on Lung Surfactant 2005 (Cycle XIV) $419,000
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
Neuronal oxidative stress from mild carbon monoxide exposure 2005 (Cycle XIV) $418,972
University of California, Los Angeles John Edmond Ph.D.
Tobacco smoke and airway remodeling in asthma 2003 (Cycle XII) $418,951
University of California, San Diego David Broide M.B., Ch.B.
Effect of smoke and gender on bronchiolar injury and repair 2005 (Cycle XIV) $418,207
University of California, Davis Laura Van Winkle Ph.D.
African Americans and Mentholated Cigarettes 1999 (Cycle VIII) $417,968
Charles R. Drew University of Medicine & Science Bruce Allen DrPH
Chemokine-based therapy for lung cancer 2001 (Cycle X) $416,940
University of California, Los Angeles Sherven Sharma Ph.D.
Irritant and pain-reducing effects of nicotine 1997 (Cycle VI) $415,704
University of California, Davis Earl Carstens Ph.D.
The role of media in smoking initiation & cessation 2001 (Cycle X) $414,203
University of California, San Diego David Burns M.D.
Effect of smoke and gender on bronchiolar injury and repair 2002 (Cycle XI) $413,288
University of California, Davis Laura Van Winkle Ph.D.
Self-hypnosis for smoking cessation 2001 (Cycle X) $413,119
University of California, San Francisco Timothy Carmody Ph.D.
Nicotine and Smoking Effects on Neuromuscular Development 1995 (Cycle IV) $412,639
Cedars-Sinai Medical Center Mario Fournier Ph.D.
Nicotine & its metabolites: apoptosis in developing neurons 2000 (Cycle IX) $412,200
Human BioMolecular Research Institute Jun Zhang Ph.D.
Effects of Outlet/Ad Density on Teen Smking and Brand Choice 2005 (Cycle XIV) $410,979
Stanford University Lisa Henriksen Ph.D.
Sex differences in nicotine effects on inflammation 2006 (Cycle XV) $410,570
University of California, San Francisco Paul Green Ph.D.
Smoking, Free Radicals, Antioxidants and Disease Prevention 1995 (Cycle IV) $408,853
University of California, Berkeley Lester Packer Ph.D.
Corporate strategies: design, conduct, publication of resrch 2004 (Cycle XIII) $407,567
University of California, San Francisco Lisa Bero Ph.D.
Mechanism of stress effects on weight in nicotine withdrawal 1998 (Cycle VII) $407,019
University of California, San Francisco Jon Levine M.D., Ph.D.
Environmental tobacco smoke effects on lung surfactant 2002 (Cycle XI) $406,444
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
Genetic susceptibility to tobacco-induced lung cancer 1998 (Cycle VII) $406,120
University of California, Los Angeles Oliver Hankinson Ph.D.
Role of protein phosphatase 2A in lung cancer 2002 (Cycle XI) $405,795
University of California, San Diego Gernot Walter Ph.D.
Lung volume reduction surgery in an emphysema model 1997 (Cycle VI) $404,139
University of California, Irvine Matthew Brenner M.D.
cGMP regulation of vascular smooth muscle differentiation 2005 (Cycle XIV) $403,818
University of California, San Diego Renate Pilz M.D.
SAR Studies of Novel antitumor Agents for Lung Carcinomas 1995 (Cycle IV) $403,338
University of California, San Diego Michael Kelner M.D., M.S.
Neurobiological substrates of nicotine addiction 2001 (Cycle X) $402,852
Scripps Research Institute Athina Markou Ph.D.
Use of existing data to develop new tobacco control strategi 2000 (Cycle IX) $402,610
University of California, San Diego Elizabeth Gilpin M.S.
Brain adaptations to chronic nicotine expsoure 1997 (Cycle VI) $402,111
University of California, Irvine Frances Leslie Ph.D.
Remnant lipoproteins, apolipoprotein E4 and atherosclerosis 2001 (Cycle X) $400,500
J. David Gladstone Institutes Robert Raffai Ph.D.
Developing new vaccines for lung cancer 1998 (Cycle VII) $398,511
University of California, Los Angeles Michael Roth M.D.
Reducing minors' access to tobacco: project CHALK 1997 (Cycle VI) $398,114
Public Health Foundation Enterprises, Inc. Hope Landrine Ph.D.
Mild carbon monoxide exposure impairs the inner ear 2005 (Cycle XIV) $397,320
University of California, Los Angeles Ivan Lopez Ph.D.
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer 2008 (Cycle XVII) $394,380
University of California, San Francisco Steven Rosen Ph.D.
Cigarette smoke injures lung epithelium by activating nSMase 2008 (Cycle XVII) $394,380
University of California, Davis Tzipora Goldkorn BSc, MSc, Ph.D.
Pharmacogenomics of New Generation Platinums in Lung Cancer 2008 (Cycle XVII) $394,380
University of California, San Francisco Kathleen Giacomini Ph.D.
Clinical Pharmacology of Tobacco Alkaloids 1995 (Cycle IV) $393,855
University of California, San Francisco Peyton Jacob Ph.D.
Preserving At Risk Tobacco Control Policy Resources 2008 (Cycle XVII) $392,644
University of California, San Francisco Karen Butter M.L.
How do nic and cig smoke affect neural control of breathing? 2004 (Cycle XIII) $392,620
University of California, Los Angeles Xuesi Shao M.D.
Fertility smoking and early mammalian development 2004 (Cycle XIII) $392,451
University of California, Riverside Prudence Talbot Ph.D.
Preserving at-risk tobacco control policy resources 2004 (Cycle XIII) $392,342
University of California, San Francisco Karen Butter M.L.
Mechanism of smoke-induced MUC5B gene expression 2001 (Cycle X) $392,117
University of California, Davis Reen Wu Ph.D.
SHS enhances cough via plasticity of brainstem neurons 2004 (Cycle XIII) $392,047
University of California, Davis Jesse Joad M.D.
Cardiac ion channels and tobacco-related disease 2002 (Cycle XI) $389,983
University of California, Santa Barbara Carol Vandenberg Ph.D.
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma 1994 (Cycle III) $389,719
University of California, San Francisco Rik Derynck Ph.D.
Preventing tobacco smoke diseases by network antioxidants 1997 (Cycle VI) $388,714
University of California, Berkeley Gladys Block Ph.D.
Macrophage DAP12 pathway in emphysema 2007 (Cycle XVI) $387,237
University of California, San Francisco Laura Koth M.D.
Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle VII) $385,808
Scripps Research Institute Carole Banka Ph.D.
Function and Regulation of the Retinoblastoma Protein 1995 (Cycle IV) $385,031
University of California, San Diego James Feramisco Ph.D.
Role of protein phosphatase 2A in lung cancer 2005 (Cycle XIV) $384,497
University of California, San Diego Gernot Walter Ph.D.
Environmental tobacco smoke and early atherosclerosis 1997 (Cycle VI) $383,814
University of Southern California Wendy Mack Ph.D.
The role of nicotine receptors in nicotine dependence 1997 (Cycle VI) $381,317
University of California, Irvine Katumi Sumikawa Ph.D.
COX-2 regulation of vaccination responses in lung cancer 2004 (Cycle XIII) $379,362
University of California, Los Angeles Steven Dubinett M.D.
Nicotinic receptors and Parkinson's disease 2002 (Cycle XI) $376,470
The Parkinson's Institute Maryka Quik Ph.D.
Role of viral-derived genes in lung cancer 1997 (Cycle VI) $375,800
Sidney Kimmel Cancer Center Francoise Mathieu-Daude Ph.D.
The geography of tobacco related disease in California 2002 (Cycle XI) $374,786
Pacific Institute for Research and Evaluation Robert Lipton BA, MA, MPH, Ph.D.
Effects of pro and anti-smoking cues in stores on craving 2004 (Cycle XIII) $373,894
Stanford University Lisa Henriksen Ph.D.
Clinical pharmacology of tobacco alkaloids 2001 (Cycle X) $373,408
University of California, San Francisco Peyton Jacob Ph.D.
Programmed cell death in cigarette-induced lung disease 1998 (Cycle VII) $371,556
University of California, San Francisco V. Courtney Broaddus M.D.
Nicotine and cardiac vulnerability to fibrillation 1997 (Cycle VI) $370,057
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Tobacco use among American Indian adolescents in California 2003 (Cycle XII) $368,975
University of Southern California Jennifer Unger Ph.D.
Ethnic difference in cigarette smoking dynamics among youth 1999 (Cycle VIII) $366,852
University of Southern California Xinguang Chen Ph.D.
Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle VI) $366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center Russell Poland Ph.D.
Role of Protein Phosphatases in Lung Cancer 1995 (Cycle IV) $363,234
University of Southern California Axel Schonthal Ph.D.
T-Cell Stimulating Antigen Genes in Tumor Cells 1994 (Cycle III) $362,814
University of California, Berkeley Nilabh Shastri Ph.D.
Tobacco Control in Latino Communities 1997 (Cycle VI) $362,153
San Diego State University Research Foundation John Elder Ph.D., M.P.H.
Mechanisms of targeted therapy resistance in lung cancer 2006 (Cycle XV) $358,500
University of California, Los Angeles Kostyantyn Krysan Ph.D.
Calorigenic and Atherogenic Effects of Smoking and Nicotine 1995 (Cycle IV) $357,492
University of California, San Francisco Marc Hellerstein M.D., Ph.D.
Effects of Tobacco Smoke on Mucin Production in Rat Airways 1995 (Cycle IV) $356,400
University of California, San Francisco Carol Basbaum Ph.D.
Gene Markers for Hypertension 1995 (Cycle IV) $356,151
University of California, San Francisco Theodore Kurtz M.D.
Vitronectin in Cardiovascular Disease 1995 (Cycle IV) $352,644
Scripps Research Institute Dietmar Seiffert M.D.
Recruitment of leukocytes to atherosclerotic lesions in vivo 1997 (Cycle VI) $352,405
University of California, San Diego Daniel Steinberg M.D., Ph.D.
Targeted blood clotting therapy for lung cancer 1999 (Cycle VIII) $350,851
University of Southern California Peisheng Hu Ph.D.
Predicting and Reducing Cigarette Sales to Minors 1995 (Cycle IV) $350,549
Public Health Foundation Enterprises, Inc. Hope Landrine Ph.D.
Virtual world internet chat room for teen smoking cessation 2000 (Cycle IX) $350,007
San Diego State University Research Foundation Susan Woodruff Ph.D.
Virtual world internet chat room for teen smoking cessation 2000 (Cycle IX) $350,007
San Diego State University Research Foundation James Crittenden
Nicotine & Neuroendocrine Cell Signalling in Fetal Lung 1995 (Cycle IV) $349,873
University of Southern California Carol Wuenschell Ph.D.
Suppression of Oncogenic Ras Mutations 1995 (Cycle IV) $348,032
University of California, Berkeley Jasper Rine Ph.D.
Prevalence and Correlates of African American Tobacco Use 2006 (Cycle XV) $347,737
San Diego State University Research Foundation Hope Landrine Ph.D.
Prevalence and Correlates of African American Tobacco Use 2006 (Cycle XV) $347,737
San Diego State University Research Foundation Scott Roesch Ph.D.
Improving tobacco use assessment among youth via telephone 1997 (Cycle VI) $347,440
University of California, Berkeley Joel Moskowitz Ph.D.
Tests of the tobacco industry's youth smoking prevention ads 2000 (Cycle IX) $343,044
Stanford University Stephen Fortmann M.D.
Smoking cessation and medical care use/costs in a large HMO 2003 (Cycle XII) $337,964
University of California, San Francisco Hai-Yen Sung Ph.D.
Prevalence and Correlates of African American Tobacco Use 2006 (Cycle XV) $335,039
California Black Health Network Denise Adams-Simms MPH
Transport and disposition of nicotine in the human placenta 1998 (Cycle VII) $333,108
University of California, San Francisco Deanna Kroetz Ph.D.
Brachial Vasoreactivity in Young Adult Smokers 1997 (Cycle VI) $332,294
Osteoporosis Medical Center Jacques Barth M.D., Ph.D.
Vitamin E kinetics in smokers 1998 (Cycle VII) $332,110
University of California, Davis Maret Traber Ph.D.
Mechanisms underlying modulations of respiration by nicotine 2001 (Cycle X) $330,458
University of California, Los Angeles Xuesi Shao M.D.
Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle IX) $329,481
University of California, Davis Walter Finkbeiner M.D., Ph.D.
Model for surveillance of CA tobacco control policies 2001 (Cycle X) $325,761
Pacific Institute for Research and Evaluation Harold Holder Ph.D.
Water pipe use, SHS exposure & home policy in Arab Americans 2005 (Cycle XIV) $323,460
San Diego State University Research Foundation Nada Kassem Dr.P.H., MS, RN
Structure-Function Correlations for Ras p21 and its Mutants 1995 (Cycle IV) $322,049
University of Southern California Arieh Warshel Ph.D.
Tobacco exposure & subclinical atherosclerosis in NIDDM 2000 (Cycle IX) $321,363
University of Southern California Wendy Mack Ph.D.
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1995 (Cycle IV) $321,199
University of California, San Diego Hyam Leffert M.D.
Fertility, Smoking, and Early Mammalian Development 1995 (Cycle IV) $321,193
University of California, Riverside Prudence Talbot Ph.D.
Cellular Defects in Lung caused by Tobacco Smoke 1995 (Cycle IV) $319,013
University of California, San Francisco Alan Verkman M.D., Ph.D.
Cigar use prevalence: social and media determinants 1997 (Cycle VI) $318,750
San Diego State University Research Foundation Joachim Reimann Ph.D.
Smoking and the pathogenesis of macular degeneration 2001 (Cycle X) $316,038
University of California, Santa Barbara Lincoln Johnson Ph.D.
Implementation of California AB 13: smoking ban in bars 1998 (Cycle VII) $315,181
University of California, San Francisco Lisa Bero Ph.D.
Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco 1994 (Cycle III) $314,974
Stanford University Gary Gibbons M.D.
Identification on Tumors of Molecular Targets for NK Cells 1995 (Cycle IV) $314,006
University of California, San Francisco William Seaman M.D.
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $311,543
Assoc of Asian Pacific Community Health Organizations Rod Lew MPH
Scientific and Administrative Core 1998 (Cycle VII) $311,057
University of Southern California C. Anderson Johnson Ph.D.
Development of a blood test for pancreatic cancer 1997 (Cycle VI) $308,819
Stanford University Anson Lowe M.D.
Role of protein phosphatase 2A in lung cancer 1999 (Cycle VIII) $307,522
University of California, San Diego Gernot Walter Ph.D.
Proteins involved in nicotine receptor clustering 2000 (Cycle IX) $307,246
University of California, San Diego William Conroy Ph.D.
Studies of novel antitumor agents for lung cancers 1998 (Cycle VII) $306,000
University of California, San Diego Michael Kelner M.D., M.S.
The Dopamine D2 Receptor in Nicotine Addiction 1995 (Cycle IV) $304,790
City of Hope National Medical Center David Comings M.D.
Transcriptional Regulation of Programmed Cell Dealth 1995 (Cycle IV) $304,418
University of California, Berkeley Astar Winoto Ph.D.
Nitrogen Oxides and cigarette smoke-induced injury 1998 (Cycle VII) $304,118
University of California, Davis Albert van der Vliet Ph.D.
Effect of tobacco-related policy change on smoking behavior 2002 (Cycle XI) $303,504
University of California, San Diego David Burns M.D.
Lesbian, gay, bisexual and transgender tobacco use 2004 (Cycle XIII) $302,119
Kaiser Foundation Research Institute Elisabeth Gruskin DrPH
Susceptibility to smoking among adolescent never smokers 1998 (Cycle VII) $301,356
University of Southern California Jennifer Unger Ph.D.
Tobacco GeneûEnvironment Interactions & Minority Asthmatics 2006 (Cycle XV) $299,500
University of California, San Francisco Shweta Choudhry Ph.D.
Tobacco, acculturation and gastric cancer among Hispanics 2005 (Cycle XIV) $298,996
University of California, Davis Lesley Butler Ph.D.
Smoking and lifestyle risk factors for premenstrual changes 1998 (Cycle VII) $297,783
University of California, Davis Ellen Gold Ph.D.
Smoking, Personality and the Risk of Parkinson's Disease 1995 (Cycle IV) $297,245
Kaiser Foundation Research Institute Stephen Van Den Eeden Ph.D.
The role of P450s in tobacco-mediated lung cancer 2001 (Cycle X) $295,815
California Toxicology Research Institute Scott Allen M.S., Ph.D.
Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle IV) $293,752
San Diego State University Research Foundation Edward Riley Ph.D.
Role of integrins in cardiac innervation and function 2000 (Cycle IX) $293,277
University of California, Santa Barbara Dennis Clegg Ph.D.
Cigar smoking among young adults: formative research 1997 (Cycle VI) $292,920
California State University, Long Beach Foundation Fen Rhodes Ph.D.
Case studies of indoor air regulations: role of research 1997 (Cycle VI) $292,210
University of California, San Francisco Lisa Bero Ph.D.
Engineering Salmonella for lung cancer therapy 2007 (Cycle XVI) $291,600
Sidney Kimmel Cancer Center Nabil Arrach Ph.D.
Interaction of LDL receptor family members with ligands 2008 (Cycle XVII) $291,600
Children's Hospital Oakland Research Institute Taichi Yamamoto Ph.D.
Modeling ETS Exposure and Dose Using PDA E-Diaries 2006 (Cycle XV) $291,531
San Diego State University Research Foundation Marilyn Johnson-Kozlow Ph.D.
Do receptors mediate the effects of nicotine on anxiety? 2005 (Cycle XIV) $291,060
Salk Institute for Biological Studies Tammy Booker Ph.D.
Smoking and virulence of periodontal pathogens 2001 (Cycle X) $289,574
Loma Linda University Hansel Fletcher Ph.D.
Expressing & Cloning of ATP-Sensitive Potassium Channels 1995 (Cycle IV) $286,163
University of California, Santa Barbara Carol Vandenberg Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle XIII) $285,300
Northern California Cancer Center Peggy Reynolds Ph.D.
African Americans: NRT or Alternative Medicine for Cessation 2006 (Cycle XV) $285,000
University of California, San Francisco Valerie Yerger ND, MA
Skeletal muscle structure and function in mice lacking VEGF 2005 (Cycle XIV) $284,500
University of California, San Diego Ivan Olfert Ph.D.
Genetics and Impulsivity in Smoking Initiation 2008 (Cycle XVII) $283,612
Veterans Medical Research Foundation Neal Doran Ph.D.
Effects of environmental tobacco smoke on pulmonary allergy 1998 (Cycle VII) $282,568
University of California, Davis Laurel Gershwin D.V.M., Ph.D.
Motivational interviewing to prevent postpartum relapse 1997 (Cycle VI) $282,502
Kaiser Foundation Research Institute Virginia Quinn MPH
Simple Exposure Indicators for Secondhand Tobacco Smoke 2006 (Cycle XV) $280,818
Lawrence Berkeley National Laboratory Lara Gundel Ph.D.
Global determinants of tobacco use onset in diverse youth 1998 (Cycle VII) $280,749
Education Training and Research Associates, Inc. Scott Carvajal Ph.D., MPH
Disproportionate cost of smoking for communities of color 2004 (Cycle XIII) $278,980
University of California, San Francisco Wendy Max Ph.D.
Control of Mucociliary Clearance in the Respiratory Tract 1995 (Cycle IV) $276,780
University of California, Los Angeles Ellen Dirksen Ph.D.
Tobacco-related cancer prevention by Vitamin A derivatives 1997 (Cycle VI) $274,488
SRI International Marcia Dawson Ph.D.
Effectiveness of two different regimens in smoking clinic 1999 (Cycle VIII) $272,989
University of California, Los Angeles Scott Eliot Sherman M.D., M.P.H.
Addressing Substance Abusers Who Also Smoke 1994 (Cycle III) $270,931
Northern California Institute for Research & Education Karen Sees D.O.
Economic Analysis of Smoking Cessation Therapies 1999 (Cycle VIII) $270,206
University of California, San Francisco James Milton Lightwood Ph.D.
Targeting the epithelial-mesenchymal transition in HNSCC 2007 (Cycle XVI) $270,000
University of California, Los Angeles Maie St. John MD, PhD
Transcription Regulation of Inflammation by Glucocorticoids 2008 (Cycle XVII) $270,000
University of California, Berkeley Jen-Chywan Wang Ph.D
Community and Family Context of Teen Smoking 2008 (Cycle XVII) $270,000
University of California, Los Angeles Ritesh Mistry Ph.D. M.P.A.
Secondhand Smoke and Nontuberculous Mycobacterial Infection 2007 (Cycle XVI) $270,000
University of California, San Diego Phung Lam Ph.D.
Influences that promote ethnic disparities in smoking 2003 (Cycle XII) $269,971
University of California, San Diego Dennis Trinidad Ph.D., M.P.H.
Smoking-related changes in LDL and atherosclerosis 2003 (Cycle XII) $269,500
University of California, San Diego Yury Miller M.D., Ph.D.
Stem cell regeneration of the airway: effects of smoke 2006 (Cycle XV) $269,500
University of California, Davis Philip Thai M.D.
Curriculum for treating nicotine dependence in psychiatry 2004 (Cycle XIII) $269,243
University of California, San Francisco Judith Prochaska Ph.D., M.P.H.
Tobacco Industry Political Strategies After the 1998 MSA 2006 (Cycle XV) $269,000
University of California, San Francisco Dorothy Apollonio Ph.D.
Tobacco industry use of diet and obesity issues 2004 (Cycle XIII) $267,526
University of California, San Francisco Elizabeth Smith Ph.D.
Enzymatic targets for anticancer therapy 2002 (Cycle XI) $267,304
J. David Gladstone Institutes Martin Bergo M.D., Ph.D.
Peripheral mechanisms of oral cancer pain in a mouse model 2003 (Cycle XII) $265,332
University of California, San Francisco Brian Schmidt DDS, MD, PhD
Hormones and Tobacco: Joint Effects on Reproduction 1994 (Cycle III) $263,611
Public Health Institute Shanna Swan Ph.D.
Molecular neurobiology of nicotine addiction 2001 (Cycle X) $263,298
University of California, Los Angeles Jim Boulter Ph.D.
How does cardiac fuel metabolism influence heart disease? 1998 (Cycle VII) $262,005
J. David Gladstone Institutes Murielle Marie Veniant Ph.D.
Effect of tobacco related policy change on smoking behavior 1999 (Cycle VIII) $261,672
University of California, San Diego David Burns M.D.
A Methodological Multi-Ethnic Study of Smoking Initiation 1995 (Cycle IV) $260,978
University of California, Los Angeles Celia Kaplan DrPH
Human oocyte development and PAH exposure 2005 (Cycle XIV) $260,944
University of California, San Francisco Renee Reijo Pera Ph.D.
Predictors of Cigarette Smoking in Latino Adolescents 1997 (Cycle VI) $260,674
University of San Francisco Gerardo Marin Ph.D.
Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation 2007 (Cycle XVI) $260,203
University of California, Davis Ayala Luria Ph.D.
NMR Study of 13C Edatrexate Metabolism 1995 (Cycle IV) $258,990
University of California, Davis Thomas Jue Ph.D.
Effects of Environmental Tobacco Smoke on Pulmonary Allergy 1995 (Cycle IV) $256,805
University of California, Davis Laurel Gershwin D.V.M., Ph.D.
Cloning & Expression of the Apo-B mRNA Editing Factor 1994 (Cycle III) $254,743
J. David Gladstone Institutes Thomas Innerarity Ph.D.
Brain metabolic changes with cigarette craving 1998 (Cycle VII) $250,850
Brentwood Biomedical Research Institute Arthur Brody M.D.
Developing policy to reverse cigar trend: roles of media 1997 (Cycle VI) $249,785
University of California, San Francisco Lisa Bero Ph.D.
Analysis of a lung tumor supressor gene at 3p21.3 2001 (Cycle X) $249,438
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
Tobacco use and cessation among drug users 1998 (Cycle VII) $249,392
University of California, Los Angeles Yih-Ing Hser Ph.D.
Inheritance and Smoking in Urinary Tract & Pancreas Cancer 1995 (Cycle IV) $248,283
University of Southern California Thomas Mack M.D., M.P.H.
Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle VII) $245,584
La Jolla Institute for Molecular Medicine Carole Banka Ph.D.
Effects of Legislation on ETS Exposure in California 1997 (Cycle VI) $245,189
University of California, San Diego Arthur Farkas Ph.D.
Acculturation & cigarette smoking among Asian-Americans 1997 (Cycle VI) $244,715
University of Southern California Xinguang Chen Ph.D.
Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle VI) $242,344
Cedars-Sinai Medical Center Russell Poland Ph.D.
Evaluation of office ETS exposure in relation to AB 13 1999 (Cycle VIII) $242,063
Public Health Institute Leon Alevantis M.S.
Functional Antagonists of Nicotine 1995 (Cycle IV) $236,936
Northern California Institute for Research & Education S. Paul Berger M.D.
Aggression and Nicotine 1997 (Cycle VI) $230,326
University of California, Irvine Larry Jamner Ph.D.
Irritant and analgesic effects of nicotine 2002 (Cycle XI) $226,650
University of California, Davis Earl Carstens Ph.D.
New therapy for lung cancer using radioiodide 2000 (Cycle IX) $225,000
University of California, Los Angeles Min Huang M.D., M.S.
Carbon monoxide as a modulator of myocardial function 1999 (Cycle VIII) $225,000
University of California, Davis Ulrike Kreutzer Ph.D.
Smoking & depression in Chinese vs. non-Chinese 1999 (Cycle VIII) $225,000
University of California, San Francisco Janice Tsoh Ph.D.
Regulation of lung inflammation by the LTC4 synthase pathway 1999 (Cycle VIII) $225,000
University of California, San Diego Kenneth Serio M.D.
Neuroendocrine responses to nicotine: a physiologic probe 1998 (Cycle VII) $225,000
University of California, San Francisco Lori Karan M.D.
Lung cancer therapy with in vivo-generated dendritic cells 2001 (Cycle X) $225,000
University of California, Los Angeles Saroj Basak
Pathways of catabolism of oxidized phospholipids 2001 (Cycle X) $225,000
University of California, San Diego Peter Friedman Ph.D.
Involvement of PI3K pathway in bladder cancer invasion 2002 (Cycle XI) $224,984
University of California, Davis Colleen Sweeney Ph.D.
Nicotinic receptors & synaptic aging 2001 (Cycle X) $224,973
University of California, San Diego Jay Coggan Ph.D.
The biological basis of nicotine addiction 1997 (Cycle VI) $224,949
University of California, Riverside Bruce Cohen Ph.D.
Prospective relationship between risk perception & teen toba 2000 (Cycle IX) $224,884
University of California, San Francisco Bonnie Halpern-Felsher Ph.D.
Skeletal muscle structure and function in COPD 1999 (Cycle VIII) $224,842
University of California, San Diego Timothy Gavin Ph.D.
Gene Augmentation Therapy for Tobacco Induced Emphysema 1995 (Cycle IV) $224,786
University of California, Davis Robert Malone M.D.
COPD: oxygen transport and metabolism in skeletal muscle 2001 (Cycle X) $224,500
University of California, San Diego Luke Haseler Ph.D.
Vascular endothelial growth factor receptor signaling 2000 (Cycle IX) $224,500
University of California, San Francisco Timothy Quinn M.D.
Predictors of adolescent smoking initiation and cessation 1998 (Cycle VII) $224,374
University of California, San Diego Won Choi Ph.D.
Activation of NF-kB by cigarette smoke 1999 (Cycle VIII) $224,217
University of California, Davis Richart Harper M.D.
Effects of tobacco on inflammatory cell responses 1997 (Cycle VI) $223,585
University of California, Davis Lisa Miller Ph.D.
Interdependence - smoking behavior & mood in natural setting 1997 (Cycle VI) $222,843
University of California, Los Angeles Richard Olmstead Ph.D.
An economic analysis of factors influencing teen smoking 1998 (Cycle VII) $221,497
University of California, San Diego Sherry Emery MBA, Ph.D.
Alterations in gene expression after tobacco smoke exposure 1997 (Cycle VI) $216,612
University of California, Davis Ken Yoneda M.D.
Economic Impact of Secondhand Smoke for Communities of Color 2007 (Cycle XVI) $216,038
University of California, San Francisco Wendy Max Ph.D.
Effect of sidestream smoke on lung injury and repair 1997 (Cycle VI) $214,070
University of California, Davis Laura Van Winkle Ph.D.
50000 Fold Signal Enhancement for Imaging Vulnerable Plaque 2007 (Cycle XVI) $213,845
Huntington Medical Research Institute Pratip Bhattacharya Ph.D.
Acculturation, media, peers, parents and adolescent smoking 1998 (Cycle VII) $213,511
University of Southern California Jennifer Unger Ph.D.
p53 Mutations in Sporadic & Familial Childhood Tumors 1994 (Cycle III) $213,407
University of California, Davis Sara Bodner M.D.
Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle IV) $211,090
J. David Gladstone Institutes Beatriz Levy-Wilson Ph.D.
Deposition of inhaled carcinogens in ETS 2001 (Cycle X) $210,446
University of California, Irvine Michael Oldham M.S.
Evaluation of office ETS exposure in relation to AB13 1999 (Cycle VIII) $208,554
Lawrence Berkeley National Laboratory William Fisk B.S., M.S.
Smoking, Nicotine, Sleep & Mood in Normals & Depression 1995 (Cycle IV) $207,434
University of California, San Diego J. Christian Gillin M.D.
Does nicotine increase sprouting of pericyte tubes? 2004 (Cycle XIII) $207,300
La Jolla Institute for Molecular Medicine Ugur Ozerdem M.D.
Effects of Tobacco Taxation Upon Population Health Status 1997 (Cycle VI) $206,547
University of California, San Diego Robert Kaplan Ph.D.
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $204,722
Asian Pacific Partners for Empowerment Advocacy & Leadership Rod Lew MPH
Evaluating Mechanisms of Change in a Smoking Intervention 2008 (Cycle XVII) $202,500
RAND Corporation Harold Green Ph.D.
Effects of exposure to secondhand smoke 1999 (Cycle VIII) $194,404
Kaiser Foundation Research Institute Carlos Iribarren M.D., Ph.D., M.P.H.
Smoking, estrogen metabolites & cognitive function 2000 (Cycle IX) $193,049
University of California, San Diego Donna Kritz-Silverstein Ph.D.
Ad and Movie Imagery and Teen's Perceptions About Smokers 1995 (Cycle IV) $190,616
University of California, Irvine Cornelia Pechmann Ph.D.
Secondhand smoke promotes chemical toxicity in fetal lung 1997 (Cycle VI) $190,536
University of California, Davis Frederick Royce M.D.
Genomics & transcriptome of oral precncr prgrssion in smkers 2004 (Cycle XIII) $189,541
University of California, Los Angeles Xiaofeng Zhou Ph.D.
Novel Approaches to Lung Cancer Research 2006 (Cycle XV) $189,486
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Does nicotine exposure inhibit convective drug delivery ? 2007 (Cycle XVI) $189,400
La Jolla Bioengineering Institute Ugur Ozerdem M.D.
Nicotine effects on neurological development 1999 (Cycle VIII) $189,233
University of California, Irvine Raju Metherate Ph.D.
Assessing nicotine relapse in a mouse model 2001 (Cycle X) $183,804
SRI International Taline Khroyan Ph.D.
Neurotoxic effects of nicotine: anatomy, mechanisms, effects 1999 (Cycle VIII) $183,424
University of California, Los Angeles Gaylord Ellison Ph.D.
Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis 1994 (Cycle III) $175,409
Stanford University Stephen Ruoss M.D.
Recruitment of leucocytes to atherosclerotic lesions in vivo 2000 (Cycle IX) $175,102
University of California, San Diego Daniel Steinberg M.D., Ph.D.
The eff of nicot on brain activity & neurocognition in schiz 2003 (Cycle XII) $167,964
University of California, Irvine Kirsten Fleming Ph.D.
Will ApoE cause regression of atherosclerotic lesions? 1998 (Cycle VII) $165,299
J. David Gladstone Institutes Robert Pitas Ph.D.
Effectiveness Evaluation of the I Decide Program 2006 (Cycle XV) $162,304
University of Southern California Louise Rohrbach Ph.D., M.P.H.
Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle XIII) $158,853
Lawrence Livermore National Laboratory Francesco Marchetti Ph.D.
Human oocyte development and PAH exposure 2005 (Cycle XIV) $158,556
Stanford University Renee Reijo Pera Ph.D.
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $155,791
San Diego State University Research Foundation Asa Gustafsson Ph.D.
Mechanisms of Tobacco-Induced Retinal Neovascularization 2006 (Cycle XV) $155,550
Stanford University John Cooke M.D., Ph.D.
Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle VII) $155,135
University of California, Berkeley Bruce Ames Ph.D.
Tobacco radioactivity & public health policy 2005 (Cycle XIV) $154,367
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
The angiogenic role of interleukin-8 in lung cancer 2000 (Cycle IX) $152,785
La Jolla Institute for Molecular Medicine Ingrid Schraufstatter M.D.
Effect of nicotine on fetal hemopoietic stem cell migration 2002 (Cycle XI) $152,352
La Jolla Institute for Molecular Medicine Sophia Khaldoyanidi M.D., Ph.D.
Explaining racial differences in smoking 1999 (Cycle VIII) $151,430
San Diego State University Research Foundation Hope Landrine Ph.D.
Tobacco-related cancer prevention by Vitamin A derivatives 1997 (Cycle VI) $149,947
Molecular Medicine Research Institute Marcia Dawson Ph.D.
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $149,610
CSU Fullerton Auxiliary Services Corporation Sora Park Tanjasiri DrPH, MPH
Nitric oxide-dependent cell signaling in vascular cells 2000 (Cycle IX) $149,557
University of California, San Diego Tanima Gudi Ph.D.
Explaining racial differences in smoking 1999 (Cycle VIII) $149,280
Public Health Foundation Enterprises, Inc. Hope Landrine Ph.D.
2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth 1995 (Cycle IV) $149,221
The Burnham Institute for Medical Research Hudson Freeze Ph.D.
Social Smoking within College Drinking Environments 2006 (Cycle XV) $149,207
San Diego State University Research Foundation Mark Reed Ph.D.
Neuropharmacology of nicotine relapse 2003 (Cycle XII) $149,175
Cedars-Sinai Medical Center Xiu Liu M.D., Ph.D.
The role of P450s in tobacco-mediated lung cancer 2001 (Cycle X) $147,858
La Jolla Institute for Molecular Medicine Scott Allen M.S., Ph.D.
Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle IX) $147,758
University of California, San Francisco Walter Finkbeiner M.D., Ph.D.
Secondhand smoke contamination and resale value 2004 (Cycle XIII) $146,760
San Diego State University Research Foundation Georg Matt Ph.D.
A novel lung tumor suppressor 1997 (Cycle VI) $144,788
The Burnham Institute for Medical Research Steven Frisch Ph.D.
Toxic compounds targeted to lung tumor blood vessels 1998 (Cycle VII) $144,300
The Burnham Institute for Medical Research Erkki Ruoslahti M.D., Ph.D.
Targeted Delivery of p53 to Lung Carcinoma Cells 1995 (Cycle IV) $143,150
Sidney Kimmel Cancer Center Ruth Gjerset Ph.D.
Overcoming drug resistance in small cell lung cancer 2001 (Cycle X) $141,340
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Antiatherogenic helical segments of apo A-I 2004 (Cycle XIII) $141,230
Lawrence Berkeley National Laboratory John Bielicki Ph.D.
Tobacco Use Among Hispanics in California 1994 (Cycle III) $138,919
University of California, San Diego Ana Navarro Ph.D.
Nicotine modifies cardiac growth during adolescence 2007 (Cycle XVI) $138,600
Veterans Medical Research Foundation Wilbur Lew M.D.
Investigating College Student Cigarette Smoking Self-change 2007 (Cycle XVI) $138,596
Veterans Medical Research Foundation Mark Myers Ph.D.
Evaluation of ad strategies for preventing youth tobacco use 1997 (Cycle VI) $136,953
University of California, Irvine Cornelia Pechmann Ph.D.
A mindfulness-based approach to relapse prevention 2005 (Cycle XIV) $134,325
California Pacific Medical Center Research Institute Cassandra Vieten Ph.D.
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $134,074
Scripps Research Institute Asa Gustafsson Ph.D.
Pediatrician training to prevent children's tobacco exposure 1997 (Cycle VI) $133,852
University of California, San Francisco Eliseo Perez-Stable M.D.
Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally 2006 (Cycle XV) $133,126
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle VII) $132,367
Children's Hospital Oakland Research Institute Bruce Ames Ph.D.
The effect of nicotine and cigarette smoke on respiration 1998 (Cycle VII) $130,177
Scripps Research Institute Merrill Mitler Ph.D.
Instant SHS Feedback as a Catalyst for Smoke-Free Homes 2008 (Cycle XVII) $129,917
San Diego State University Research Foundation Neil Klepeis
Modeling cost/effectiveness of tobacco control programs 2002 (Cycle XI) $129,915
University of California, San Diego Robert Kaplan Ph.D.
Prenatal smoke exposure and age at Menarche 2002 (Cycle XI) $129,090
Sequoia Foundation Gayle Windham Ph.D.
Regulation of a novel airway glandular mucin by smoke 2004 (Cycle XIII) $126,126
University of California, Davis Yin Chen Ph.D.
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Karen Hudmon Dr.P.H., R.P.H., M.S.
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Marilyn Shreve R.Ph.
Plasma antioxidant enzymes as markers of smoke injury 1997 (Cycle VI) $123,073
Lawrence Berkeley National Laboratory Trudy Forte Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle XIII) $122,659
Public Health Institute Peggy Reynolds Ph.D.
Tobacco Products, Activin-A, and Lung Cancers 1995 (Cycle IV) $122,583
University of Southern California Shao-Yao Ying Ph.D.
Understanding and preventing college smoking 2000 (Cycle IX) $122,377
University of Southern California Donna Spruijt-Metz Ph.D.
Discovery of serum markers of lung cancer 1998 (Cycle VII) $120,300
Cedars-Sinai Medical Center Phillip Koeffler M.D.
Nicotine & cardiac vulnerability to fibrillation 2000 (Cycle IX) $120,000
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure 2000 (Cycle IX) $120,000
Scripps Research Institute Cindy Ehlers Ph.D.
Smoking, breast cancer and tobacco metabolizing genes 1999 (Cycle VIII) $120,000
Childrens Hospital, Los Angeles Jan Van Tornout M.D., M.S.
Smoking and echogenicity of the arterial intima 2000 (Cycle IX) $119,299
University of Southern California James Dwyer Ph.D.
Computer Simulation as a Tool for Reducing SHS Exposure 2007 (Cycle XVI) $118,418
Education Training and Research Associates, Inc. Neil Klepeis
Effect of tobacco smoke on lung airway surface liquid 1998 (Cycle VII) $115,658
Children's Hospital Oakland Research Institute Jacob Bastacky M.D.
Genetic links to nicotine addiction: ethics of testing teens 1999 (Cycle VIII) $115,591
Stanford University Thomas Raffin M.D.
Brain wave assessment of tobacco cessation readiness 1997 (Cycle VI) $115,487
Scripps Research Institute Aaron Ilan Ph.D.
Effects of tobacco smoke exposure on hormones and fertility 1998 (Cycle VII) $115,335
Sequoia Foundation Gayle Windham Ph.D.
African American church role in tobac